Tag: CMC

Addressing Inadequate Control Strategies during Pilot Scale Development in Pharma The transition from lab-scale to pilot-scale manufacturing presents unique challenges, particularly related to control strategies that may be inadequate, exposing…

Actionable Playbook for Addressing Inadequate Control Strategies During Development Studies In the pharmaceutical sector, a control strategy that is inadequate during development studies can lead to significant regulatory and operational…

Strategies for Managing Non-Transferable Processes in Validation Planning In the realm of pharmaceutical manufacturing and quality assurance, the transfer of processes between different stages of development or facilities is a…

Ensuring Process Transferability During Pilot Scale: Key Data Expectations In pharmaceutical manufacturing and development, achieving a seamless scale-up from laboratory to pilot scale is critical for ensuring later-stage regulatory success.…

Managing Process Variability During Pilot Scale Operations: A Practical Playbook In pharmaceutical manufacturing, particularly during pilot scale operations, the risk of process variability exceeding established limits poses severe regulatory scrutiny.…

Managing Regulatory Risks Related to Inadequate Control Strategies During Pilot Scale Operations In the realm of pharmaceutical manufacturing, pilot scale operations are a crucial step in the journey from formulation…

Mitigating Risks of Inadequate Control Strategies During Development Studies Pharmaceutical professionals involved in formulation and process development are frequently faced with the challenge of ensuring that their control strategies meet…

Strategies for Addressing Poorly Defined CPPs in Development Studies In the realm of pharmaceutical development, the inadequacy of Critical Process Parameters (CPPs) can lead to significant challenges, particularly during scale-up…

Minimizing Regulatory Scrutiny Risks When CPPs are Poorly Defined In the pharmaceutical manufacturing landscape, it is increasingly crucial to ensure that Critical Process Parameters (CPPs) are well-defined throughout the regulatory…

Aligning Critical Process Parameters During Lifecycle Optimization in Pharma In the fast-paced world of pharmaceutical manufacturing, failure to clearly define Critical Process Parameters (CPPs) during lifecycle optimization can lead to…

Improving Process Robustness Amid Yield Loss in Pilot Scale Optimization Yield loss during optimization in pilot scale operations poses significant challenges for pharmaceutical companies. Each incidence of yield loss not…

Strategic Approaches for Addressing Poor Justification of Design Space During Validation Planning In the pharmaceutical industry, the successful transition from formulation development to commercial production hinges on a well-defined design…